Lactoferrin Versus Ferrous Sulphate for Treatment of Iron Deficiency Anaemia During Pregnancy
Launched by AIN SHAMS MATERNITY HOSPITAL · Mar 22, 2018
Trial Information
Current as of June 18, 2025
Completed
Keywords
ClinConnect Summary
Lactoferrin and Ferrous sulfate are used to treat iron deficiency anemia in pregnancy.
Ferrous sulphate is the most commonly used treatment for iron deficiency anemia.
Lactoferrin is a new generation oral iron that has long been recognized as a member of the transferrin family of proteins and an important regulator of the levels of free iron in the body fluids and has the ability to enhance iron binding. Preliminary evidence suggests that lactoferrin may represent a promising new strategy for oral iron replacement.
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • Pregnant women with single fetus
- • Hb count \< 11g/dL
- • ferritin level \< 12 ng/dL
- • Gestational age (14 - 30 weeks)
- Exclusion Criteria:
- • Associated chronic medical disorder (CKD, liver disease, peptic ulcer and chronic blood loss).
- • Associated bleeding disorder
- • Anaemia requiring blood tranfusion (Hb \< 7g/dL)
- • Hypersensitivity to iron preparations
- • Haemoglobinopathies (G6PD, thalassemias, sickle cell disease)
About Ain Shams Maternity Hospital
Ain Shams Maternity Hospital is a leading healthcare institution dedicated to providing comprehensive maternal and neonatal care. With a commitment to advancing women's health, the hospital engages in innovative clinical research and trials aimed at improving treatment outcomes and enhancing patient care. Equipped with state-of-the-art facilities and a team of experienced healthcare professionals, Ain Shams Maternity Hospital fosters a collaborative environment for research that prioritizes safety, efficacy, and ethical standards. Through its clinical trials, the hospital seeks to contribute to the global body of knowledge in obstetrics and gynecology, ultimately benefiting patients and healthcare providers alike.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Cairo, , Egypt
Patients applied
Trial Officials
Ahmed Mamdouh
Study Director
Ain Shams Maternity Hospital
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials